Navigation Links
Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
Date:10/20/2009

ARDEE, Ireland, Oct. 20 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where he was responsible for directing global preclinical development activities.

"Dr. Fawzi is joining Warner Chilcott during a very exciting period in the company's history," said Roger Boissonneault, Warner Chilcott's President and Chief Executive Officer. "We look forward to the contributions he will make based on his experience and numerous achievements along the spectrum of R&D activities, from pre-development to life cycle management and commercial phases of drug development."

Prior to joining Warner Chilcott, Dr. Fawzi spent nearly 15 years with Wyeth, most recently as Executive Vice President, Preclinical Development where he led the development and launch of numerous new drugs. During his tenure, he was selected as one of four finalists for the Pharmaceutical Executive of the Year award. Prior to Wyeth, Dr. Fawzi also held positions with Warner Lambert, The Procter & Gamble Company and Pfizer, Inc.

Dr. Fawzi received his Bachelor of Science in Pharmacy from the University of Bagdad and his Masters and Doctorate in Pharmaceutical Chemistry from the University of Michigan.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

SOURCE Warner Chilcott plc


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
2. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
3. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
4. UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
5. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
6. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
7. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
8. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
9. Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels
10. Vincent W. Renz Joins NewCardio as President
11. Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)...  Ethicon* today announced the completion of its ... medical device company that manufactures and markets the ... of Gastroesophageal Reflux Disease (GERD). This acquisition is ... of minimally invasive options for patients suffering from ... the transaction have not been disclosed. ...
(Date:3/23/2017)... A research report by Mordor Intelligence ... reach USD 7.2 billion by the end of 2021 and ... procedure in which a sample is preserved prior to its ... since the methods are often allowing repeated testing. The report ... shared procedures in the lab. In many life science labs, ...
(Date:3/23/2017)... DENVER , March 23, 2017  Drug ... pain medication misuse and deadly overdoses. A new ... Health Solutions, www.cordantsolutions.com , reports more detailed ... tests, which can potentially improve therapy adherence, patient ... The Cordant Comprehensive Oral fluid Rx Evaluation ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... ... families and businesses of the Norwalk and Vermillion areas, celebrates the newest ... (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer recovery support ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... SmartBen NOW, an innovative mobile app and centralized benefits dashboard solving one of ... information securely from multiple locations. For the first time, employees can access up-to-date ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Los Angeles based healthcare technology company California Healthcom Group (CHG). , The ... and healthcare arena. With headquarters in California, CHG is a growing, internationally recognized ...
(Date:3/23/2017)... ... ... The TouchPoint Solution, home of Buzzies *, is boosting the Arizona ... “Buzzies change the way we interact with stress and live our day-to-day lives,” said ... in December 2016, The TouchPoint Solution has sold more than $750,000 in product sales. ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, ... enables organizations to easily reprint customer invoices, bills, statements and other correspondence when ... the steps needed to retrieve and print the documents and batch them for ...
Breaking Medicine News(10 mins):